Repeated Intrastromal Injections of Voriconazole in Combination with Corneal Debridement for Recalcitrant Fungal Keratitis – a Case Series

I. Guber; C. Bergin; F. Majo

doi:10.1055/s-0041-111814

Klinische Monatsblätter für Augenheilkunde, Inhaltsverzeichnis

Klin Monbl Augenheilkd 2016; 233(04): 369-372
DOI: 10.1055/s-0041-111814

Kasuistik

Georg Thieme Verlag KG Stuttgart · New York

Repeated Intrastromal Injections of Voriconazole in Combination with Corneal Debridement for Recalcitrant Fungal Keratitis – a Case Series

Wiederholte intrastromale Injektionen mit Voriconazol in Verbindung mit Hornhaut-Debridement bei der Behandlung resistenter Pilzkeratiden – eine Fallserie

I. Guber

Department of Ophthalmology, University of Lausanne, Fondation Asile des aveugles, Jules-Gonin Eye Hospital, Lausanne, Switzerland (Chair: Prof. Francine Behar-Cohen)

,

C. Bergin

Department of Ophthalmology, University of Lausanne, Fondation Asile des aveugles, Jules-Gonin Eye Hospital, Lausanne, Switzerland (Chair: Prof. Francine Behar-Cohen)

,

F. Majo

Department of Ophthalmology, University of Lausanne, Fondation Asile des aveugles, Jules-Gonin Eye Hospital, Lausanne, Switzerland (Chair: Prof. Francine Behar-Cohen)

› Institutsangaben

Abstract

Background: To report the use of intrastromal voriconazole injections combined with corneal debridement to treat deep recalcitrant fungal keratitis. History and Signs: Three patients (2 female and 1 male) with culture proven fungal keratitis (1 Fusarium, 1 Candida, 1 Pseudallescheria boydii) were included in this study. The patients were treated with repeated intrastromal voriconazole (100 mg/1 ml) in combination with corneal debridement. Therapy and Outcome: The mean age of the patients was 65 years. The mean number of injections was 5. The patients were injected every 2–3 days. This technique required repeated corneal debridement to achieve complete resolution in these three cases. Conclusions: Repeated intrastromal injection of voriconazole in combination with corneal debridement appears to be an effective and safe way to treat recalcitrant fungal keratitis, even in Fusarium keratitis.

Zusammenfassung

Hintergrund: Ziel der Studie war es, die Wirksamkeit intrastromaler Voriconazol Injektionen und Hornhaut-Debridement bei der Behandlung resistenter Pilzinfektionen zu überprüfen. Anamnese und Befunde: Insgesamt wurden drei konsekutive Patienten (2 Frauen, 1 Mann) mit gesicherter Pilzkeratitis (1 Fusarium, 1 Candida, 1 Pseudallescheria boydii) in diese Studie eingeschlossen. Die Patienten wurden mit wiederholten intrastromalen Injektionen mit Voriconazol (100 mg/1 ml) behandelt. Therapie und Verlauf: Das Durchschnittsalter der Patienten betrug 65 Jahre. Im Durschnitt wurden 5 Injektionen im Abstand von 3 Tagen durchgeführt. Bei allen Patienten war die Behandlung (d. h. wiederholte Injektionen und Abkratzen der Hornhaut) erfolgreich. Schlussfolgerungen: Intrastromale Injektionen scheinen eine sichere und effektive Option bei der Behandlung resistenter Pilzkeratiden (sogar bei Fusarium Keratitis) zu sein.

Key words

voriconazole - VFend - fungal keratitis - intrastromal injection

Schlüsselwörter

Voriconazol - VFend - Pilzkeratitis - intrastromale Injektionen

Volltext

Referenzen

References
1 OʼDay D, Head W, Robinson R et al. Corneal penetration of topical amphotericin B and natamycin. Curr Eye Res 1986; 5: 877-882
2 Kaur IP, Rana C, Singh H. Development of effective ocular preparations of antifungal agents. J Ocul Pharmacol Ther 2008; 24: 481-493
3 Srinivasan M. Fungal keratitis. Curr Opin Ophthalmol 2004; 15: 321-327
4 Diekema DJ, Messer SA, Hollis RJ et al. Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi. J Clin Microbiol 2003; 41: 3623-3626
5 Hariprasad SM, Mieler WF, Lin TK et al. Voriconazole in the treatment of fungal eye infections: a review of current literature. Br J Ophthalmol 2008; 92: 871-878
6 Kernt M, Kampik A. Intracameral Voriconazole: in vitro safety for human ocular cells. Toxicology 2009; 258: 84-93
7 Hariprasad SM, Mieler WF, Lin TK et al. Voriconazole in the treatment of fungal eye infections: a review of current literature. Br J Ophthalmol 2008; 92: 871-878
8 Prakash G, Sharma N, Goel M et al. Evaluation of intrastromal injection of voriconazole as a therapeutic adjunctive for the management of deep recalcitrant fungal keratitis. Am J Ophthalmol 2008; 146: 56-59
9 Sharma N, Agarwal P, Sinha R et al. Evaluation of intrastromal voriconazole injection in recalcitrant deep fungal keratitis: case series. Br J Ophthalmol 2011; 95: 1735-1737
10 Mittal V, Mittal R. Intracameral and topical voriconazole for fungal corneal endoexudates. Cornea 2012; 31: 366-370
11 Wiederhold NP, Lewis RE. Antifungal activity against Scedosporium species and novel assays to assess antifungal pharmacodynamics against filamentous fungi. Med Mycol 2009; 47: 422-432
12 Chowdhary A, Singh K. Spectrum of fungal keratitis in North India. Cornea 2005; 24: 8-15
13 Panda A, Vajpayee RB, Kumar TS. Critical evaluation of therapeutic keratoplasty in cases of keratomycosis. Ann Ophthalmol 1991; 23: 373-376
14 Garcia-Valenzuela E, Song CD. Intracorneal injection of amphotericin B for recurrent fungal keratitis and endophthalmitis. Arch Ophthalmol 2005; 123: 1721-1723
15 Siatiri H, Daneshgar F, Siatiri N et al. The effects of intrastromal voriconazole injection and topical voriconazole in the treatment of recalcitrant Fusarium keratitis. Cornea 2011; 30: 872-875
16 Tu EY. Alternaria keratitis: clinical presentation and resolution with topical fluconazole or intrastromal voriconazole and topical caspofungin. Cornea 2009; 28: 116-119
17 Neoh CF, Leung L, Vajpayee RB et al. Treatment of Alternaria keratitis with intrastromal and topical caspofungin in combination with intrastromal, topical, and oral voriconazole. Ann Pharmacother 2011; 45: e24
18 Jain V, Borse N, Shome D et al. Recalcitrant fungal tunnel infection treated with intrastromal injection of voriconazole. Int Ophthalmol 2010; 30: 723-725
19 Chandra J, Mukherjee PK. Candida Biofilms: Development, Architecture, and Resistance. Microbiol Spectr 2015; 3
20 Lalitha P, Prajna NV, Kabra A et al. Risk factor for treatment outcome in fungal keratitis. Ophthalmology 2006; 113: 526-530
21 Alastruey-Izquierdo A, Cuenca-Estrella M, Monzón A et al. Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods. J Antimicrob Chemother 2008; 61: 805-809
22 OʼShaughnessy EM, Meletiadis J, Stergiopoulou T et al. Antifungal interactions within the triple combination of amphotericin B, caspofungin and voriconazole against Aspergillus species. J Antimicrob Chemother 2006; 58: 1168-1176
23 Thiel MA, Zinkernagel AS, Burhenne J et al. Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis. Antimicrob Agents Chemother 2007; 51: 239-244
24 Shen YC, Wang CY, Tsai HY et al. Intracameral voriconazole injection in the treatment of fungal endophthalmitis resulting from keratitis. Am J Ophthalmol 2010; 149: 916-921